Aclarion, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Aclarion, Inc. now
Current reporting with the operating signal separated from the noise.
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal
The story matters when it changes Aclarion, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
Investors are testing whether Aclarion, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Aclarion, Inc.: Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
The development tests whether Aclarion, Inc. can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Aclarion, Inc. to Present NOCISCAN at State of Spine Surgery Think Tank in Cabo San Lucas
The story matters when it changes Aclarion, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ACON filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Aclarion, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →